MAPT and progressive supranuclear palsy: However, the observed polymorphisms in tau filaments with P301 mutations suggest that such models should be used with caution in the study of tau pathologies of either Alzheimer’s disease or sporadic 4R tauopathies, such as progressive supranuclear palsy.